MVZ OrthoCentrum Hamburg Takes Next Growth Steps Together with Ortheum
Livingstone has advised the orthopaedic practice group OrthoCentrum Hamburg on the sale of a majority stake to the orthopaedic platform Ortheum, managed by Deutsche Private Equity. The shareholders Prof. Dr. Holz, Dr. Ilg, Prof. Dr. Hansen-Algenstaedt, and Dr. Schneider continue to hold a significant stake in the company.
Founded in 1992, MVZ OrthoCentrum Hamburg operates three orthopaedic practice sites in Hamburg and Schleswig-Holstein with an integrated practice-clinic concept that optimally combines conservative and surgical treatment.
Since its inception, the group has continuously evolved and has gained an extensive reputation for its focus on and specialization in arthroscopic and minimally invasive procedures on the extremities, endoprosthetics of shoulder, knee, and hip joints, as well as the entire spectrum of foot and spinal surgery. Every year, 2,500 operations are performed in the affiliated clinics, both as inpatient and increasingly as outpatient procedures, by specialized surgeons and supervised by scientific staff before and after the operation. The MVZ OrthoCentrum Hamburg currently employs around 50 employees and specialists.
The Ortheum Group, part of the Deutsche Private Equity investment company’s portfolio, has acquired a majority stake in MVZ OrthoCentrum. The renowned practice group strengthens the growing Ortheum Group in Northern Germany. The merger will support the future growth of the practice group and further develop the regional partner network in Hamburg.
“For many years, OrthoCentrum has stood for excellence in orthopaedic and trauma surgery combined with first-class conservative treatment of orthopaedic patients. Our practice group particularly benefits from the ambulantization in the healthcare sector and, together with the affiliated hospitals and acute clinics, has positioned itself optimally for further growth. Together with Ortheum, we will rapidly expand our presence in Hamburg and the surrounding area and increase our position as a leading orthopaedic care provider,” said Prof. Dr. Johannes Holz, Managing Partner of MVZ OrthoCentrum Hamburg. “Our special thanks go to the Livingstone team, led by Mr. Grandin, who actively supported OrthoCentrum in a complex transaction with a great deal of expertise, including in the medical and regulatory field.”
Sibylle Stauch-Eckmann, CEO of Ortheum, commented: “We are pleased to move into the operational implementation and expansion of the Ortheum Group in the North with OrthoCentrum Hamburg after an intensive negotiation phase. The support and structuring of our partnership were conducted very professionally and on an equal footing by Mr. Grandin and his team from Livingstone.”
Christian Grandin, Managing Partner at Livingstone, said: “In supporting the shareholders of the MVZ OrthoCentrum, our expertise in the healthcare sector was just as important as the business structuring and creative planning of the MVZ operation. In Ortheum, we found a partner for the dynamic plans of the shareholders who shares their vision regarding the ongoing outpatientization of orthopaedic and trauma surgery and who will successfully accompany them along the way.”
This is the Livingstone Healthcare team’s eleventh successful transaction in the last twelve months, following the sale of NEUROMEDEX to PINOVA, several financing rounds of neoplas med, three successful divestitures for Centers for Autism & Related Disorders, LLC, and the sale of Narconova to Ortivity / Apheon, among others.
